Who are Salicylic Acid (6%)'s main competitors?

Direct comparators (same drug class / molecular target / therapeutic area): ABPO Forte Gel, Benzoyl Peroxide Topical, Canthardin Collodion, Benzoyl peroxide 5% gel, Thioglycolic Acid, BPO.

How often does this brief refresh?

Every 30 minutes from primary sources (FDA, EMA, MHRA, PMDA, ClinicalTrials.gov, USPTO). Subscribe to the RSS feed below for push alerts.

How do I get this as a recurring report?

Subscribe to /feed/ci/salicylic-acid-6.xml in any RSS reader (Feedly, Inoreader, NewsBlur). Every regulatory action, trial readout, or patent event lands in your feed automatically.

Last reviewed 2026-05-16 · How we verify

Salicylic Acid (6%) — Competitive Intelligence Brief

Salicylic Acid (6%) (Salicylic Acid (6%)) competitive landscape: 6 comparators, recent regulatory actions, upcoming PDUFA, patent timeline. Class: Keratolytic agent. Area: Dermatology.

marketed Keratolytic agent Dermatology Small molecule Live · refreshed every 30 min

Target snapshot

Salicylic Acid (6%) (Salicylic Acid (6%)) — Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh. Salicylic acid works as a keratolytic agent that softens and dissolves the outer layer of skin, promoting exfoliation and removal of dead skin cells.

Comparator set (6 drugs)

Auto-detected by same drug class / molecular target / therapeutic area, ranked by phase + recency. Override with ?vs=slug1,slug2,….

Drug	Generic	Sponsor	Phase	Class	Target
Salicylic Acid (6%) TARGET	Salicylic Acid (6%)	Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh	marketed	Keratolytic agent
ABPO Forte Gel	ABPO Forte Gel	Galderma R&D	marketed	Topical antimicrobial and keratolytic agent	Bacterial protein synthesis inhibition; mitochondrial oxidative stress in bacteria
Benzoyl Peroxide Topical	Benzoyl Peroxide Topical	University of Missouri-Columbia	marketed	Topical antimicrobial and keratolytic agent
Canthardin Collodion	Canthardin Collodion	Medical University of South Carolina	marketed	Vesicant / keratolytic agent	Protein phosphatase 2A (PP2A)
Benzoyl peroxide 5% gel	Benzoyl peroxide 5% gel	University of Southern California	marketed	Topical antimicrobial and keratolytic agent
Thioglycolic Acid	Thioglycolic Acid	Hospital de Clinicas de Porto Alegre	marketed	Chemical depilatory / keratolytic agent	Disulfide bonds in keratin protein
BPO	BPO	Galderma R&D	marketed	Topical antimicrobial and keratolytic agent	Cutibacterium acnes (bacterial target); non-specific oxidative mechanism

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape (Keratolytic agent class)

Assistance Publique - Hôpitaux de Paris · 1 drug in this class
Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh · 1 drug in this class

Subscribe to ongoing alerts

Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:

Cite this brief

Drug Landscape (2026). Salicylic Acid (6%) — Competitive Intelligence Brief. https://druglandscape.com/ci/salicylic-acid-6. Accessed 2026-05-16.

Build your own brief

Pick any drug + add comparators:

https://druglandscape.com/ci/{slug} — auto-detected competitors
https://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3 — explicit comparators
Brand names auto-resolve: /ci/keytruda → 301 → /ci/pembrolizumab